AIP mutations are not identified in patients with sporadic pituitary adenomas

Endocrine Pathology

Volumn 18, Issue 2, 2007, Pages 76-78

  DiGiovanni, Rebecca ^a   Serra, Stefano ^a   Ezzat, Shereen ^b   Asa, Sylvia L ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acromegaly; AIP; Mutation; Pituitary

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; GENOMIC DNA;

ACROMEGALY; ARTICLE; BLOOD; CARCINOGENESIS; CLINICAL ARTICLE; ENDOCRINE DISEASE; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; LEUKOCYTE; MUTATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ACROMEGALY; ADENOMA; CANADA; COHORT STUDIES; DNA; DNA, NEOPLASM; EXONS; GENE FREQUENCY; GERM-LINE MUTATION; HUMANS; PITUITARY NEOPLASMS; PROTEINS;

EID: 35348826087     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-007-0010-z     Document Type: Article

References (17)

1. Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas: a systematic review. Cancer 101(3):613-9, 2004.
2. Asa SL, Ezzat S. The pathogenesis of pituitary tumours. Nat Rev Cancer 2(11):836-49, 2002.
3. Ezzat S, Asa SL. Mechanisms of disease: The pathogenesis of pituitary tumors. Nat Clin Pract Endocrinol Metab 2(4):220-30, 2006.
4. Asa SL. Tumors of the pituitary gland. Atlas of tumor pathology, third series, fascicle 22. Washington, D.C.: Armed Forces Institute of Pathology; 1998.
5. Vallar L, Spada A, Giannattasio G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330:566-8, 1987.
6. Vierimaa O, Georgitsi M, Lehtonen R, et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312(5777):1228-30, 2006.
7. Kuzhandaivelu N, Cong YS, Inouye C, Yang WM, Seto E. XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res 24(23):4741-50, 1996.
8. Carlson DB, Perdew GH. A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J Biochem Mol Toxicol 16(6):317-25, 2002.
9. Kashuba EV, Gradin K, Isaguliants M, et al. Regulation of transactivation function of the aryl hydrocarbon receptor by the Epstein-Barr virus-encoded EBNA-3 protein. J Biol Chem 281(2):1215-23, 2006.
10. Yu R, Bonert V, Saporta I, Raffel LJ, Melmed S. Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas. J Clin Endocrinol Metab 91(12):5126-9, 2006.
11. DeLellis RA, Lloyd RV, Heitz PU, Eng C. Pathology and genetics of tumours of endocrine organs. WHO classification of tumours. Lyons: IARC Press; 2004.
12. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404-7, 1997.
13. Kirschner LS, Carney JA, Pack SD, et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26(1):89-92, 2000.
14. Gadelha MR, Une KN, Rohde K, Vaisman M, Kineman RD, Frohman LA. Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12. J Clin Endocrinol Metab 85(2):707-14, 2000.
15. Asa SL, Somers K, Ezzat S. The MEN-1 gene is rarely down-regulated in pituitary adenomas. J Clin Endocrinol Metab 83:3210-2, 1998.
16. Yamasaki H, Mizusawa N, Nagahiro S, et al. GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24. Clin Endocrinol (Oxf) 58 (4):464-70, 2003.
17. Kaltsas GA, Kola B, Borboli N, et al. Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours. Clin Endocrinol (Oxf) 57(4):443-8, 2002.